These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25968090)

  • 41. A prospective study of appetite and food craving in 30 patients with Cushing's disease.
    Geer EB; Lalazar Y; Couto LM; Cohen V; Lipton LR; Shi W; Bagiella E; Conwell I; Bederson J; Kostadinov J; Post KD; Freda PU
    Pituitary; 2016 Apr; 19(2):117-26. PubMed ID: 26496766
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quality of Life in Cushing's disease: A long term issue?
    Webb SM; Santos A; Resmini E; Martínez-Momblán MA; Martel L; Valassi E
    Ann Endocrinol (Paris); 2018 Jun; 79(3):132-137. PubMed ID: 29625700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Persistent adrenocorticotropin response to desmopressin in the early postoperative period predicts recurrence of Cushing's disease.
    Losa M; Bianchi R; Barzaghi R; Giovanelli M; Mortini P
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3322-8. PubMed ID: 19584185
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Maximizing the accuracy of Inferior petrosal sinus sampling: validation of the use of Prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing's disease.
    Grant P; Dworakowska D; Carroll P
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):555-9. PubMed ID: 22017348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Normal long-term health-related quality of life can be achieved in patients with functional pituitary adenomas having surgery as primary treatment.
    Ritvonen E; Karppinen A; Sintonen H; Vehkavaara S; Kivipelto L; Roine RP; Niemelä M; Schalin-Jäntti C
    Clin Endocrinol (Oxf); 2015 Mar; 82(3):412-21. PubMed ID: 25039500
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of the construct validity of the Health Utilities Index Mark 3 (HUI3) in patients with schizophrenia.
    Luo N; Seng BK; Thumboo J; Feeny D; Li SC
    Qual Life Res; 2006 Jun; 15(5):889-98. PubMed ID: 16721648
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The quality of life in adult patients treated for Cushing's disease in childhood.
    Pasternak-Pietrzak K; Moszczyńska E; Szalecki M
    Pediatr Endocrinol Diabetes Metab; 2021; 27(2):93-99. PubMed ID: 34514766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mapping CushingQoL scores onto SF-6D utility values in patients with Cushing's syndrome.
    Roset M; Badia X; Forsythe A; Webb SM
    Patient; 2013; 6(2):103-11. PubMed ID: 23549927
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A combined test using desmopressin and corticotropin-releasing hormone in the differential diagnosis of Cushing's syndrome.
    Newell-Price J; Perry L; Medbak S; Monson J; Savage M; Besser M; Grossman A
    J Clin Endocrinol Metab; 1997 Jan; 82(1):176-81. PubMed ID: 8989255
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcome of Cushing's disease following transsphenoidal surgery in a single center over 20 years.
    Hassan-Smith ZK; Sherlock M; Reulen RC; Arlt W; Ayuk J; Toogood AA; Cooper MS; Johnson AP; Stewart PM
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1194-201. PubMed ID: 22278423
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Predictive factors for neurocognitive function and Quality of Life after surgical treatment for Cushing's disease and acromegaly.
    Psaras T; Milian M; Hattermann V; Will BE; Tatagiba M; Honegger J
    J Endocrinol Invest; 2011; 34(7):e168-77. PubMed ID: 21060251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adrenocorticotropin- and cortisol-releasing effect of hexarelin, a synthetic growth hormone-releasing peptide, in normal subjects and patients with Cushing's syndrome.
    Ghigo E; Arvat E; Ramunni J; Colao A; Gianotti L; Deghenghi R; Lombardi G; Camanni F
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2439-44. PubMed ID: 9253314
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.
    Assié G; Bahurel H; Coste J; Silvera S; Kujas M; Dugué MA; Karray F; Dousset B; Bertherat J; Legmann P; Bertagna X
    J Clin Endocrinol Metab; 2007 Jan; 92(1):172-9. PubMed ID: 17062771
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Construct validation and comparison of a novel postoperative quality-of-life metric and the Short Form-36 in colorectal surgery patients.
    Keller DS; McGee MF; Goyal S; Nobel T; O'Brien Ermlich B; Cheruvu VK; Delaney CP
    Surgery; 2013 Oct; 154(4):690-5; discussion 695-6. PubMed ID: 24074407
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical and biochemical characteristics of adrenocorticotropin-secreting macroadenomas.
    Woo YS; Isidori AM; Wat WZ; Kaltsas GA; Afshar F; Sabin I; Jenkins PJ; Monson JP; Besser GM; Grossman AB
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4963-9. PubMed ID: 15886242
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relapsing, remitting hypercortisolism in Cushing's disease due to intratumoral hemorrhages in pituitary microadenoma.
    Marko NF; Hamrahian AH; Hatipoglu B; Weil RJ
    J Clin Neurosci; 2013 May; 20(5):753-6. PubMed ID: 23352667
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circadian blood pressure profile in patients with active Cushing's disease and after long-term cure.
    Pecori Giraldi F; Toja PM; De Martin M; Maronati A; Scacchi M; Omboni S; Cavagnini F; Parati G
    Horm Metab Res; 2007 Dec; 39(12):908-14. PubMed ID: 18046661
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of Cushing's disease: outcome in patients with microadenoma detected on pituitary magnetic resonance imaging.
    Prevedello DM; Pouratian N; Sherman J; Jane JA; Vance ML; Lopes MB; Laws ER
    J Neurosurg; 2008 Oct; 109(4):751-9. PubMed ID: 18826366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered neural processing of emotional faces in remitted Cushing's disease.
    Bas-Hoogendam JM; Andela CD; van der Werff SJ; Pannekoek JN; van Steenbergen H; Meijer OC; van Buchem MA; Rombouts SA; van der Mast RC; Biermasz NR; van der Wee NJ; Pereira AM
    Psychoneuroendocrinology; 2015 Sep; 59():134-46. PubMed ID: 26092780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.